GE Aerospace's income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), GE Aerospace reported revenue of $45.9B (+18.5% year on year) and net income of $8.7B (+32.8% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Sales | $42.3B | $35.1B | $64.6B | $73.6B |
| Insurance revenue (Note 12) | $3.5B | $3.6B | $3.4B | $3.0B |
| Total revenue | $45.9B | $38.7B | $68.0B | $76.6B |
| Cost of sales | $29.0B | $24.3B | $50.4B | $55.5B |
| Selling, general and administrative expenses | $4.1B | $4.4B | $9.2B | $12.8B |
| Separation costs | $202.0M | $492.0M | $978.0M | $973.0M |
| Research and development | $1.6B | $1.3B | $1.9B | $2.8B |
| Interest and other financial charges | $843.0M | $986.0M | $1.1B | $1.6B |
| Insurance losses, annuity benefits and other costs (Note 12) | $2.4B | $2.4B | $2.9B | $2.7B |
| Goodwill impairments (Note 7) | $0 | $251.0M | — | $0 |
| Non-operating benefit cost (income) | ($788.0M) | ($842.0M) | ($1.6B) | ($532.0M) |
| Total costs and expenses | $37.3B | $33.3B | $64.9B | $76.4B |
| Other income (loss) (Note 19) | $1.5B | $2.3B | $7.1B | $1.2B |
| Income (loss) from continuing operations before income taxes | $10.0B | $7.6B | $10.2B | $1.4B |
| Benefit (provision) for income taxes (Note 15) | ($1.4B) | ($962.0M) | ($1.2B) | ($476.0M) |
| Income (loss) from discontinued operations, net of taxes (Note 2) | $103.0M | ($91.0M) | $414.0M | ($644.0M) |
| Net income (loss) | $8.7B | $6.6B | $9.4B | $292.0M |
| Less net income (loss) attributable to noncontrolling interests | ($6.0M) | $11.0M | ($37.0M) | $67.0M |
| Net income (loss) attributable to the Company | $8.7B | $6.6B | $9.5B | $225.0M |
| Net income (loss) from continuing operations | $8.6B | $6.7B | $9.0B | $936.0M |
| Less net income (loss) attributable to noncontrolling interests, continuing operations | ($6.0M) | ($13.0M) | ($38.0M) | $67.0M |
| Net income (loss) from continuing operations attributable to the Company | $8.6B | $6.7B | $9.1B | $869.0M |
| Preferred stock dividends and other | $0 | $0 | ($295.0M) | — |
| Net income (loss) from continuing operations attributable to common shareholders | $8.6B | $6.7B | $8.8B | $581.0M |
| Net income (loss) from discontinued operations attributable to common shareholders | $103.0M | ($114.0M) | — | — |
| Net income (loss) attributable to common shareholders | $8.7B | $6.6B | $9.2B | ($64.0M) |
| Diluted earnings (loss) per share (in dollars per share) | $8.05 | $6.09 | $7.98 | $0.53 |
| Basic earnings (loss) per share (in dollars per share) | $8.11 | $6.15 | $8.06 | $0.53 |
| Diluted earnings (loss) per share (in dollars per share) | $8.14 | $5.99 | $8.36 | -$0.05 |
| Basic earnings (loss) per share (in dollars per share) | $8.20 | $6.04 | $8.44 | -$0.06 |
| Line item | Sep 30, 2026 · Q3 | Jun 30, 2026 · Q2 | Mar 31, 2026 · Q1 | Sep 30, 2025 · Q3 |
|---|---|---|---|---|
| Sales | $13.3B | $12.6B | $11.6B | $11.3B |
| Insurance revenue (Note 12) | $833.0M | $715.0M | $778.0M | $875.0M |
| Total revenue | $14.1B | $13.3B | $12.4B | $12.2B |
| Cost of sales | $9.1B | $8.7B | $7.9B | $7.8B |
| Selling, general and administrative expenses | $1.1B | $1.1B | $1.1B | $1.2B |
| Separation costs | $3.0M | $34.0M | $55.0M | $53.0M |
| Research and development | $458.0M | $460.0M | $440.0M | $415.0M |
| Interest and other financial charges | $231.0M | $215.0M | $230.0M | $225.0M |
| Insurance losses, annuity benefits and other costs (Note 12) | $1.0B | $524.0M | $624.0M | $500.0M |
| Non-operating benefit cost (income) | ($178.0M) | ($177.0M) | ($176.0M) | ($198.0M) |
| Total costs and expenses | $11.7B | $10.9B | $10.2B | $10.0B |
| Other income (loss) (Note 18) | $432.0M | $313.0M | ($16.0M) | $285.0M |
| Income (loss) from continuing operations before income taxes | $2.8B | $2.8B | $2.2B | $2.5B |
| Benefit (provision) for income taxes (Note 15) | ($385.0M) | ($407.0M) | ($252.0M) | ($344.0M) |
| Net income (loss) from continuing operations | $2.4B | $2.4B | $1.9B | $2.2B |
| Income (loss) from discontinued operations, net of taxes (Note 2) | ($124.0M) | ($38.0M) | ($26.0M) | ($17.0M) |
| Net income (loss) | $2.3B | $2.4B | $1.9B | $2.2B |
| Less net income (loss) attributable to noncontrolling interests | $8.0M | ($13.0M) | $16.0M | ($3.0M) |
| Net income (loss) attributable to the Company | $2.3B | $2.4B | $1.9B | $2.2B |
| Net income (loss) attributable to common shareholders | $2.3B | $2.4B | $1.9B | $2.2B |
| Diluted earnings (loss) per share (in dollars per share) | $2.32 | $2.30 | $1.83 | $2.04 |
| Basic earnings (loss) per share (in dollars per share) | $2.33 | $2.31 | $1.85 | $2.06 |
| Diluted earnings (loss) per share (in dollars per share) | $2.20 | $2.26 | $1.81 | $2.02 |
| Basic earnings (loss) per share (in dollars per share) | $2.21 | $2.28 | $1.82 | $2.04 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash, cash equivalents and restricted cash | $12.4B | $13.6B | $17.0B | $17.3B |
| Investment securities (Note 3) | $0 | $982.0M | $5.7B | $7.6B |
| Current receivables (Note 4) | $11.8B | $9.3B | $15.5B | $18.0B |
| Inventories, including deferred inventory costs (Note 5) | $11.9B | $9.8B | $16.5B | $17.4B |
| Current contract assets (Note 8) | $3.5B | $3.0B | $1.5B | $3.1B |
| All other current assets (Note 9) | $1.1B | $962.0M | $1.6B | $1.5B |
| Current assets | $40.6B | $37.6B | $59.8B | $66.2B |
| Investment securities (Note 3) | $38.8B | $37.7B | $38.0B | $36.0B |
| Property, plant and equipment – net (Note 6) | $8.0B | $7.3B | $12.5B | $14.5B |
| Goodwill (Note 7) | $9.1B | $8.5B | $13.4B | $25.8B |
| Other intangible assets – net (Note 7) | $4.2B | $4.3B | $5.7B | $7.6B |
| Contract and other deferred assets (Note 8) | $4.9B | $4.8B | $5.4B | $6.0B |
| All other assets (Note 9) | $15.3B | $13.9B | $16.0B | $17.0B |
| Deferred income taxes (Note 15) | $7.5B | $7.1B | $10.6B | $11.7B |
| Assets of discontinued operations (Note 2) | $1.9B | $1.8B | $1.7B | $2.9B |
| Total assets | $130.2B | $123.1B | $163.0B | $187.8B |
| Short-term borrowings (Note 10) | $1.7B | $2.0B | $1.3B | $3.8B |
| Accounts payable (Note 11) | $10.1B | $7.9B | — | — |
| Progress collections (Note 8) | $7.7B | $6.7B | — | — |
| Contract liabilities and deferred income (Note 8) | $10.3B | $9.4B | $19.7B | $18.1B |
| Sales discounts and allowances (Note 14) | $4.0B | $3.5B | — | — |
| All other current liabilities (Note 14) | $5.2B | $4.9B | $12.7B | $14.5B |
| Current liabilities | $39.0B | $34.4B | $50.9B | $56.9B |
| Deferred income (Note 8) | $1.1B | $1.0B | $1.3B | $2.0B |
| Long-term borrowings (Note 10) | $18.8B | $17.2B | $19.7B | $28.6B |
| Insurance liabilities and annuity benefits (Note 12) | $36.9B | $36.2B | $39.6B | $33.3B |
| Non-current compensation and benefits | $6.8B | $7.0B | $11.2B | $16.0B |
| All other liabilities (Note 14) | $7.3B | $6.4B | $10.5B | $12.2B |
| Liabilities of discontinued operations (Note 2) | $1.4B | $1.3B | $1.2B | $1.1B |
| Total liabilities | $111.3B | $103.6B | $134.5B | $150.2B |
| Common stock (1,048,766,702 and 1,073,692,183 shares outstanding at December 31, 2025 and December 31, 2024, respectively) (Note 16) | 15.0M | 15.0M | 15.0M | 15.0M |
| Accumulated other comprehensive income (loss) – net attributable to the Company (Note 16) | ($4.8B) | ($3.9B) | ($6.2B) | ($1.3B) |
| Other capital | $23.6B | $24.3B | $27.0B | $34.2B |
| Retained earnings | $87.7B | $80.5B | $86.5B | $84.7B |
| Less common stock held in treasury | ($87.8B) | ($81.6B) | ($80.0B) | ($81.2B) |
| Total shareholders’ equity | $18.7B | $19.3B | $27.4B | $36.4B |
| Noncontrolling interests | $221.0M | $223.0M | $1.2B | $1.2B |
| Total equity | $18.9B | $19.6B | $28.6B | $37.6B |
| Total liabilities and equity | $130.2B | $123.1B | $163.0B | $187.8B |
| Line item | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Sep 30, 2025 |
|---|---|---|---|---|
| Cash, cash equivalents and restricted cash | $8.8B | $9.3B | $11.0B | $12.5B |
| Current receivables (Note 4) | $14.0B | $12.4B | $12.5B | $10.7B |
| Inventories, including deferred inventory costs (Note 5) | $12.7B | $12.4B | $12.4B | $11.7B |
| Current contract assets (Note 8) | $3.5B | $3.5B | $3.4B | $3.1B |
| All other current assets (Note 9) | $2.5B | $2.1B | $1.1B | $1.1B |
| Current assets | $41.5B | $39.7B | $40.4B | $40.1B |
| Investment securities (Note 3) | $35.9B | $37.9B | $38.2B | $1.0B |
| Property, plant and equipment – net (Note 6) | $8.3B | $8.1B | $8.0B | $7.6B |
| Goodwill (Note 7) | $9.0B | $9.0B | $9.0B | $9.0B |
| Other intangible assets – net (Note 7) | $4.0B | $4.1B | $4.2B | $4.3B |
| Contract and other deferred assets (Note 8) | $5.0B | $5.0B | $5.0B | $4.7B |
| All other assets (Note 9) | $15.3B | $15.5B | $15.2B | $15.6B |
| Deferred income taxes (Note 15) | $6.8B | $6.9B | $7.0B | $6.8B |
| Assets of discontinued operations (Note 2) | $1.4B | $1.5B | $1.7B | $2.0B |
| Total assets | $127.2B | $127.7B | $128.4B | $128.2B |
| Short-term borrowings (Note 10) | $2.3B | $2.0B | $2.1B | $2.1B |
| Accounts payable (Note 11) | $11.0B | $10.8B | $10.7B | $9.5B |
| Progress collections (Note 8) | $8.2B | $7.9B | $7.7B | $7.0B |
| Contract liabilities and deferred income (Note 8) | $10.3B | $10.2B | $10.2B | $9.9B |
| Sales discounts and allowances (Note 14) | $5.6B | $5.0B | $5.0B | $4.0B |
| All other current liabilities (Note 14) | $4.9B | $4.5B | $4.3B | $4.8B |
| Current liabilities | $42.4B | $40.4B | $40.0B | $37.2B |
| Deferred income (Note 8) | $976.0M | $1.1B | $1.1B | $1.1B |
| Long-term borrowings (Note 10) | $17.0B | $17.2B | $18.2B | $18.8B |
| Insurance liabilities and annuity benefits (Note 12) | $34.1B | $36.2B | $35.7B | $37.2B |
| Non-current compensation and benefits | $6.4B | $6.5B | $6.7B | $6.7B |
| All other liabilities (Note 14) | $7.4B | $7.3B | $7.2B | $7.0B |
| Liabilities of discontinued operations (Note 2) | $1.1B | $1.1B | $1.3B | $1.3B |
| Total liabilities | $109.4B | $109.8B | $110.1B | $109.2B |
| Common stock (1,033,351,921 and 1,048,766,702 shares outstanding at September 30, 2026 and December 31, 2025, respectively) (Note 16) | 15.0M | 15.0M | 15.0M | 15.0M |
| Accumulated other comprehensive income (loss) – net attributable to the Company (Note 16) | ($5.1B) | ($4.9B) | ($4.5B) | ($4.3B) |
| Other capital | $22.9B | $23.1B | $23.1B | $23.6B |
| Retained earnings | $92.8B | $91.0B | $89.1B | $85.5B |
| Less common stock held in treasury | ($93.1B) | ($91.5B) | ($89.7B) | ($86.0B) |
| Total shareholders’ equity | $17.5B | $17.6B | $18.1B | $18.8B |
| Noncontrolling interests | $228.0M | $227.0M | $240.0M | $209.0M |
| Total equity | $17.8B | $17.9B | $18.3B | $19.0B |
| Total liabilities and equity | $127.2B | $127.7B | $128.4B | $128.2B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Net income (loss) | $8.7B | $6.6B | $9.4B | $292.0M |
| Net (income) loss from discontinued operations activities | ($103.0M) | $91.0M | ($414.0M) | $644.0M |
| Depreciation and amortization of property, plant and equipment (Note 6) | $863.0M | $834.0M | $1.5B | $1.8B |
| Amortization of intangible assets (Note 7) | $357.0M | $350.0M | $606.0M | $1.7B |
| Goodwill impairments (Note 7) | $0 | $251.0M | — | $0 |
| (Gains) losses on equity securities (Note 19) | ($508.0M) | ($719.0M) | ($5.8B) | $144.0M |
| Principal pension plans (benefit) cost (Note 13) | ($655.0M) | ($653.0M) | ($1.1B) | $575.0M |
| Principal pension plans employer contributions | ($211.0M) | ($210.0M) | ($212.0M) | ($325.0M) |
| Other postretirement benefit plans (net) | ($230.0M) | ($299.0M) | ($644.0M) | ($1.2B) |
| Provision (benefit) for income taxes (Note 15) | $1.4B | $962.0M | $1.2B | $476.0M |
| Cash recovered (paid) during the year for income taxes (Note 15) | ($739.0M) | ($334.0M) | ($1.1B) | ($1.1B) |
| Decrease (increase) in current receivables | ($2.4B) | ($1.1B) | ($833.0M) | ($3.0B) |
| Decrease (increase) in inventories, including deferred inventory costs | ($2.0B) | ($1.5B) | ($1.5B) | ($2.3B) |
| Decrease (increase) in current contract assets | ($511.0M) | ($112.0M) | $1.3B | $1.5B |
| Increase (decrease) in contract liabilities and current deferred income | $1.1B | $1.1B | — | — |
| Increase (decrease) in progress collections | $838.0M | $531.0M | $2.9B | $2.5B |
| Increase (decrease) in accounts payable | $2.0B | $688.0M | ($221.0M) | $2.8B |
| Increase (decrease) in sales discounts and allowances (Note 14) | $562.0M | ($266.0M) | — | — |
| All other operating activities | $136.0M | ($326.0M) | $717.0M | $1.2B |
| Cash from (used for) operating activities – continuing operations | $8.5B | $5.8B | $5.6B | $5.9B |
| Cash from (used for) operating activities – discontinued operations | ($6.0M) | ($1.1B) | ($391.0M) | $52.0M |
| Cash from (used for) operating activities | $8.5B | $4.7B | $5.2B | $5.9B |
| Additions to property, plant and equipment and internal-use software | ($1.3B) | ($1.0B) | ($1.6B) | — |
| Dispositions of property, plant and equipment | $123.0M | $114.0M | $89.0M | $209.0M |
| Proceeds from principal business dispositions | $0 | $499.0M | $0 | $15.0M |
| Net cash from (payments for) principal businesses purchased | ($360.0M) | ($135.0M) | ($365.0M) | ($30.0M) |
| Sales of retained ownership interests | $0 | $5.3B | — | $4.7B |
| Net (purchases) dispositions of insurance investment securities (Note 3) | $425.0M | ($963.0M) | ($986.0M) | ($876.0M) |
| All other investing activities | $309.0M | ($4.3B) | $791.0M | ($726.0M) |
| Cash from (used for) investing activities – continuing operations | ($776.0M) | ($556.0M) | $6.9B | $1.8B |
| Cash from (used for) investing activities – discontinued operations | ($377.0M) | ($1.1B) | ($3.0B) | $444.0M |
| Cash from (used for) investing activities | ($1.2B) | ($1.7B) | $4.0B | $2.3B |
| Net increase (decrease) in borrowings (maturities of 90 days or less) | $25.0M | $2.0M | ($55.0M) | $65.0M |
| Newly issued debt (maturities longer than 90 days) | $2.0B | $0 | $11.0M | $8.2B |
| Repayments and other debt reductions (maturities longer than 90 days) | ($1.8B) | ($788.0M) | ($3.4B) | ($11.2B) |
| Dividends paid to shareholders | ($1.5B) | ($1.0B) | ($589.0M) | ($639.0M) |
| Redemption of preferred stock | $0 | $0 | ($5.8B) | — |
| Purchases of common stock for treasury | ($7.6B) | ($5.8B) | ($1.2B) | — |
| All other financing activities | $120.0M | $992.0M | $410.0M | ($1.3B) |
| Cash from (used for) financing activities – continuing operations | ($8.7B) | ($6.6B) | ($10.6B) | ($5.6B) |
| Cash from (used for) financing activities – discontinued operations | $0 | ($98.0M) | $2.0B | $0 |
| Cash from (used for) financing activities | ($8.7B) | ($6.7B) | ($8.6B) | ($5.6B) |
| Effect of currency exchange rate changes on cash, cash equivalents and restricted cash | $201.0M | ($193.0M) | $120.0M | ($369.0M) |
| Increase (decrease) in cash, cash equivalents and restricted cash | ($1.1B) | ($3.9B) | $664.0M | $2.2B |
| Cash, cash equivalents and restricted cash at beginning of year | $15.9B | $19.8B | $19.1B | $16.9B |
| Line item | Sep 30, 2026 · YTD | Jun 30, 2026 · YTD | Mar 31, 2026 · Q1 | Sep 30, 2025 · YTD |
|---|---|---|---|---|
| Net income (loss) | $6.6B | $4.3B | $1.9B | $6.1B |
| Net (income) loss from discontinued operations activities | $188.0M | $65.0M | $26.0M | ($14.0M) |
| Depreciation and amortization of property, plant and equipment (Note 6) | $679.0M | $452.0M | $227.0M | $643.0M |
| Amortization of intangible assets (Note 7) | $282.0M | $173.0M | $85.0M | $270.0M |
| (Gains) losses on equity securities (Note 18) | $7.0M | $173.0M | $271.0M | ($177.0M) |
| Principal pension plans (benefit) cost (Note 13) | ($439.0M) | ($293.0M) | ($147.0M) | ($488.0M) |
| Principal pension plans employer contributions | ($145.0M) | ($97.0M) | ($49.0M) | ($144.0M) |
| Other postretirement benefit plans (net) | ($199.0M) | ($136.0M) | ($79.0M) | ($194.0M) |
| Provision (benefit) for income taxes | $1.0B | $658.0M | $252.0M | $1.0B |
| Cash recovered (paid) during the year for income taxes | ($284.0M) | ($141.0M) | ($34.0M) | ($437.0M) |
| Decrease (increase) in current receivables | ($2.4B) | ($694.0M) | ($709.0M) | ($1.3B) |
| Decrease (increase) in inventories, including deferred inventory costs | ($965.0M) | ($643.0M) | ($534.0M) | ($1.8B) |
| Decrease (increase) in current contract assets | ($22.0M) | $32.0M | $68.0M | ($116.0M) |
| Increase (decrease) in contract liabilities and current deferred income | $48.0M | ($135.0M) | ($91.0M) | $593.0M |
| Increase (decrease) in progress collections | $535.0M | $281.0M | $55.0M | $173.0M |
| Increase (decrease) in accounts payable | $916.0M | $856.0M | $668.0M | $1.5B |
| Increase (decrease) in sales discounts and allowances (Note 14) | $1.6B | $956.0M | $1.0B | $554.0M |
| All other operating activities | ($100.0M) | ($658.0M) | ($1.1B) | $180.0M |
| Cash from (used for) operating activities – continuing operations | $7.3B | $5.1B | $1.9B | $6.4B |
| Cash from (used for) operating activities – discontinued operations | ($159.0M) | ($108.0M) | ($44.0M) | ($191.0M) |
| Cash from (used for) operating activities | $7.2B | $5.0B | $1.8B | $6.3B |
| Additions to property, plant and equipment and internal-use software | ($1.0B) | ($666.0M) | ($331.0M) | ($842.0M) |
| Dispositions of property, plant and equipment | $179.0M | $58.0M | $13.0M | $76.0M |
| Net cash from (payments for) principal businesses purchased | ($1.0M) | ($1.0M) | $0 | ($360.0M) |
| Net (purchases) dispositions of insurance investment securities | ($289.0M) | ($7.0M) | ($351.0M) | $595.0M |
| All other investing activities | ($1.8B) | ($1.2B) | ($206.0M) | ($795.0M) |
| Cash from (used for) investing activities – continuing operations | ($2.9B) | ($1.9B) | ($875.0M) | ($1.3B) |
| Cash from (used for) investing activities – discontinued operations | ($169.0M) | ($110.0M) | ($44.0M) | ($131.0M) |
| Cash from (used for) investing activities | ($3.1B) | ($2.0B) | ($919.0M) | ($1.5B) |
| Net increase (decrease) in borrowings (maturities of 90 days or less) | $467.0M | ($20.0M) | — | $17.0M |
| Newly issued debt (maturities longer than 90 days) | $0 | — | — | $2.0B |
| Repayments and other debt reductions (maturities longer than 90 days) | ($1.3B) | ($1.0B) | ($60.0M) | ($1.3B) |
| Dividends paid to shareholders | ($1.4B) | ($873.0M) | ($381.0M) | ($1.1B) |
| Purchases of common stock for treasury | ($6.5B) | ($4.5B) | ($2.4B) | ($5.6B) |
| All other financing activities | $178.0M | $54.0M | $9.0M | $71.0M |
| Cash from (used for) financing activities – continuing operations | ($8.5B) | ($6.4B) | ($2.8B) | ($5.9B) |
| Cash from (used for) financing activities – discontinued operations | $0 | $0 | $0 | $0 |
| Cash from (used for) financing activities | ($8.5B) | ($6.4B) | ($2.8B) | ($5.9B) |
| Effect of currency exchange rate changes on cash, cash equivalents and restricted cash | ($79.0M) | ($68.0M) | ($57.0M) | $189.0M |
| Increase (decrease) in cash, cash equivalents and restricted cash | ($4.5B) | ($3.4B) | ($2.0B) | ($868.0M) |
| Cash, cash equivalents and restricted cash at beginning of year | $14.8B | $14.8B | $14.8B | $15.9B |
| Cash, cash equivalents and restricted cash at September 30 | $10.3B | — | — | $15.0B |
| Less cash, cash equivalents and restricted cash of discontinued operations at September 30 | ($735.0M) | ($854.0M) | ($1.0B) | ($1.2B) |
| Cash, cash equivalents and restricted cash of continuing operations at September 30 | $9.5B | $10.5B | $11.8B | $13.8B |
GE Aerospace score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.